European Urology Focus

Slides:

Advertisements

Similar presentations

Diana Cardona-Grau, Igor Sorokin, Gabriel Leinwand, Charles Welliver

Advertisements

European Urology Focus

Maria Carmen Mir, Cesar Ercole, Andrew Stephenson

Judith Bosschieter, André N. Vis, Henk G. van der Poel, Luc M

European Urology Focus

Volume 71, Issue 6, Pages (June 2017)

Volume 51, Issue 2, Pages (February 2007)

The Impact of Case Finding on the Recruitment Yield for COPD Research in Primary Care: An Observational Study Respiration 2016;92: DOI: /

Volume 58, Issue 4, Pages (October 2010)

Volume 66, Issue 6, Pages (December 2014)

European Urology Focus

Volume 58, Issue 1, Pages (July 2010)

Volume 60, Issue 2, Pages (August 2011)

Volume 66, Issue 2, Pages (August 2014)

Volume 199, Issue 4, Pages e235-e236 (April 2018)

European Urology Oncology

Volume 49, Issue 2, Pages (February 2006)

Volume 68, Issue 3, Pages (September 2015)

Volume 51, Issue 4, Pages (April 2007)

Volume 51, Issue 3, Pages (March 2007)

European Urology Oncology

Volume 65, Issue 5, Pages (May 2014)

Volume 53, Issue 5, Pages (May 2008)

Volume 72, Issue 5, Pages (November 2017)

Volume 61, Issue 4, Pages (April 2012)

Volume 63, Issue 4, Pages (April 2013)

Volume 63, Issue 1, Pages (January 2013)

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

European Urology Oncology

Volume 71, Issue 6, Pages (June 2017)

Nomograms for Bladder Cancer

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 66, Issue 4, Pages (October 2014)

Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 4, Pages (April 2012)

Volume 60, Issue 5, Pages (November 2011)

Volume 67, Issue 3, Pages (March 2015)

Volume 64, Issue 5, Pages (November 2013)

Volume 61, Issue 6, Pages (June 2012)

European Urology Oncology

Volume 66, Issue 6, Pages (December 2014)

Volume 61, Issue 6, Pages (June 2012)

Volume 71, Issue 6, Pages (June 2017)

Volume 74, Issue 3, Pages (September 2018)

Volume 66, Issue 6, Pages (December 2014)

Volume 66, Issue 6, Pages (December 2014)

Volume 63, Issue 3, Pages (March 2013)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 71, Issue 4, Pages (April 2017)

Volume 53, Issue 1, Pages (January 2008)

Selma Masic, Janet E. Cowan, Samuel L. Washington, Hao G

Volume 52, Issue 6, Pages (December 2007)

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Volume 74, Issue 4, Pages (October 2018)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements E. Schaden, O. Kimberger, P. Kraincuk, D.M.

Prognostic Impact of Comorbidity in Patients with Bladder Cancer

Bladder Cancer: Highlights from 2006

Volume 75, Issue 4, Pages (April 2019)

European Urology Oncology

Volume 75, Issue 2, Pages (February 2019)

Volume 54, Issue 2, Pages (August 2008)

Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 51, Issue 2, Pages (February 2007)

Oncoforum Urology: Prostate Cancer 2008 at a Glance

Volume 54, Issue 1, Pages (July 2008)

European Urology Oncology

Maximilian Burger, Ashish M. Kamat, David McConkey

Presentation transcript:

European Urology Focus Impact of Packed Red Blood Cells and Fresh Frozen Plasma Given During Radical Cystectomy and Urinary Diversion on Cancer-related Outcome and Survival: An Observational Cohort Study Marc A. Furrer, Adrian Fellmann, Marc P. Schneider, George N. Thalmann, Fiona C. Burkhard, Patrick Y. Wuethrich European Urology Focus DOI: 10.1016/j.euf.2017.09.010 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 Flow chart with inclusion and exclusion criteria used in the analysis. European Urology Focus DOI: (10.1016/j.euf.2017.09.010) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 Kaplan–Meyer estimates of (A) disease recurrence-free, (B) cancer-specific, and (C) overall survival among patients with muscle-invasive bladder cancer treated with radical cystectomy by receipt of either PRBC alone (blue) or PRBC and FFP (red). FFP=fresh frozen plasma; PRBC=packed red blood cell. European Urology Focus DOI: (10.1016/j.euf.2017.09.010) Copyright © 2017 European Association of Urology Terms and Conditions